Private Capital Group’s Genomic Health, Inc. GHDX Stock Holding History

Private Capital Group’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-27	Closed	-$2K	–	2310
2019 Q3	$2K	Sell	27 -58	-68%	-$3.98K	﹤0.01%	1961
2019 Q2	$4K	Buy	85 +33	+63%	+$1.96K	﹤0.01%	1754
2019 Q1	$4K	Sell	52 -33	-39%	-$2.45K	﹤0.01%	1757
2018 Q4	$5K	Hold	85	–	–	﹤0.01%	1646
2018 Q3	$5K	Hold	85	–	–	﹤0.01%	1725
2018 Q2	$4K	Sell	85 -2	-2%	-$79	﹤0.01%	1748
2018 Q1	$3K	Sell	87 -4,003	-98%	-$133K	﹤0.01%	1789
2017 Q4	$5	Buy	+4,090	New	+$130K	﹤0.01%	1671

Private Capital Group's GHDX Position: Q4 2019 in Review

Private Capital Group sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 27 shares — an estimated $2K sold.

Private Capital Group first reported a position in GHDX in Q4 2017 and held it in 8 quarters. The position peaked at $5K in Q4 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Private Capital Group reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Private Capital Group sold 27 Genomic Health, Inc. shares in Q4 2019, an estimated $2K.
Private Capital Group first reported a position in Genomic Health, Inc. in Q4 2017 and held it in 8 quarters.
Private Capital Group's Genomic Health, Inc. position peaked at $5K in Q4 2018.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Private Capital Group's 13F filing for Q4 2019, filed 14 Feb 2020.